Literature DB >> 31256653

Reduced opioid requirements following unicompartmental knee arthroplasty compared with total knee arthroplasty.

I L Kalbian1, T L Tan2, A J Rondon2, V A Bonaddio1, M R Klement2, C Foltz2, J H Lonner2.   

Abstract

AIMS: Unicompartmental knee arthroplasty (UKA) provides improved early functional outcomes and less postoperative morbidity and pain compared with total knee arthroplasty (TKA). Opioid prescribing has increased in the last two decades, and recently states in the USA have developed online Prescription Drug Monitoring Programs to prevent overprescribing of controlled substances. This study evaluates differences in opioid requirements between patients undergoing TKA and UKA. PATIENTS AND METHODS: We retrospectively reviewed 676 consecutive TKAs and 241 UKAs. Opioid prescriptions in morphine milligram equivalents (MMEs), sedatives, benzodiazepines, and stimulants were collected from State Controlled Substance Monitoring websites six months before and nine months after the initial procedures. Bivariate and multivariate analysis were performed for patients who had a second prescription and continued use.
RESULTS: Patients undergoing UKA had a second opioid prescription filled 50.2% of the time, compared with 60.5% for TKA (p = 0.006). After controlling for potential confounders, patients undergoing UKA were still less likely to require a second prescription than those undergoing TKA (adjusted odds ratio (OR) 0.58, 95% confidence interval (CI) 0.42 to 0.81; p = 0.001). Continued opioid use requiring more than five prescriptions occurred in 13.7% of those undergoing TKA and 5.8% for those undergoing UKA (p = 0.001), and was also reduced in UKA patients compared with TKA patients (adjusted OR 0.33, 95% CI 0.16 to 0.67; p = 0.022) in multivariate analysis. The continued use of opioids after six months was 11.8% in those undergoing TKA and 8.3% in those undergoing UKA (p = 0.149). The multivariate models for second prescriptions, continued use with more than five, and continued use beyond six months yielded concordance scores of 0.70, 0.86, and 0.83, respectively.
CONCLUSION: Compared with TKA, patients undergoing UKA are less likely to require a second opioid prescription and use significantly fewer opioid prescriptions. Thus, orthopaedic surgeons should adjust their patterns of prescription and educate patients about the reduced expected analgesic requirements after UKA compared with TKA. Cite this article: Bone Joint J 2019;101-B(7 Supple C):22-27.

Entities:  

Keywords:  Narcotic; Opioid; Postoperative management; Retrospective; Total knee arthroplasty; Unicompartmental knee arthroplasty

Mesh:

Substances:

Year:  2019        PMID: 31256653     DOI: 10.1302/0301-620X.101B7.BJJ-2018-1454.R1

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  4 in total

1.  Pain management of unicompartmental (UKA) vs. total knee arthroplasty (TKA) based on a matched pair analysis of 4144 cases.

Authors:  Franziska Leiss; Julia Sabrina Götz; Günther Maderbacher; Florian Zeman; Winfried Meissner; Joachim Grifka; Achim Benditz; Felix Greimel
Journal:  Sci Rep       Date:  2020-10-19       Impact factor: 4.379

2.  An opioid-sparing protocol with intravenous parecoxib can effectively reduce morphine consumption after simultaneous bilateral total knee arthroplasty.

Authors:  Hsuan-Hsiao Ma; Te-Feng Arthur Chou; Hsin-Yi Wang; Shang-Wen Tsai; Cheng-Fong Chen; Po-Kuei Wu; Wei-Ming Chen
Journal:  Sci Rep       Date:  2021-04-01       Impact factor: 4.379

3.  Knee Scores of Patients with Non-Lateral Compartmental Knee Osteoarthritis Undergoing Mobile, Fixed-Bearing Unicompartmental Knee and Total Knee Arthroplasties: A Randomized Controlled Trial.

Authors:  Li-Ping Wu; Hermann O Mayr; Xing Zhang; Yuan-Qiao Huang; Yuan-Zhuang Chen; Yu-Ming Li
Journal:  Orthop Surg       Date:  2021-12-06       Impact factor: 2.071

4.  Robotic Assistance in Unicompartmental Knee Arthroplasty Results in Superior Early Functional Recovery and Is More Likely to Meet Patient Expectations.

Authors:  Meredith P Crizer; Amer Haffar; Andrew Battenberg; Mikayla McGrath; Ryan Sutton; Jess H Lonner
Journal:  Adv Orthop       Date:  2021-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.